• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

M&A

Future road sign
Pharma

AbbVie touts robust Q3 as analysts query growth past immunology

AbbVie laid out a strong Q3 performance as analysts inquired after growth opportunities, potentially beyond immunology, in the coming decade.
Donavyn Coffey Oct 30, 2026 3:15pm
Sanofi headquarters Sanofi

Amid Dupixent boom, Sanofi looks hard at its R&D future

Oct 30, 2026 11:50am
puzzle pieces merger and acquisition business concept

Consulting firm Blue Matter picks up comms agency Cognite

Oct 28, 2026 10:06am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Favicon Fierce Biotech

Treasury COINS rules add biotech, spares China licensing deals

Oct 22, 2026 11:36pm
Illustration connected puzzle pieces with the acronym MA

Galderma targets medical skincare growth with $1.5B Zo buyout

Oct 14, 2026 10:31am
The entrance of Asahi Kasei Corporations headquarters

Asahi Kasei makes good on AiCurus buyout with new FDA nod

Oct 12, 2026 10:28am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings